Related Experiment Videos
Clinical trials for pediatric scleroderma
Margalit E Rosenkranz1, Thomas J A Lehman
1Division of Pediatric Rheumatology, Hospital for Special Surgery, Sanford Weill Medical College, Cornell University, 535 East 70th Street, New York, NY 10021, USA. goldscout@aol.com
Insights
Progressive systemic sclerosis (PSS), a rare condition in children, often involves internal organs and reduces survival. Further multicenter research is crucial for effective pediatric PSS care.
Area of Science:
- Pediatric rheumatology
- Rare autoimmune diseases
Background:
- Progressive systemic sclerosis (PSS), also known as scleroderma, is uncommon in children.
- Internal organ involvement in pediatric PSS significantly impacts survival rates.
- Limited research exists due to the condition's rarity and diagnostic delays.
Purpose of the Study:
- To highlight the challenges in evaluating and treating pediatric PSS.
- To emphasize the need for collaborative, multicenter studies in pediatric scleroderma.
Main Methods:
- This study is a review of current understanding and challenges in pediatric PSS.
- It synthesizes information from existing literature on adult and pediatric cases.
Main Results:
- Pediatric PSS presents unique challenges compared to adult cases.
- Current treatment strategies for adults may not be directly applicable to children.
- There is a lack of robust evidence for therapeutic interventions in pediatric PSS.
Conclusions:
- Effective management of pediatric PSS requires further investigation.
- Collaborative, multicenter research is essential to understand PSS pathogenesis and optimize treatment for children.
- Improved diagnostic approaches and evidence-based therapies are needed for better patient outcomes.
Abstract:
Progressive systemic sclerosis (PSS), or scleroderma, is a rare disease in the pediatric population. Many children with PSS have significant involvement of their internal organs, which leads to decreased survival. Because of the infrequency of the condition and delayed diagnosis, there are no large studies to evaluate therapy for PSS in children. Treatment is controversial in the adult literature, and its applicability to children is unclear. Only through collaborative efforts will researchers be able to clearly delineate the etiopathogenesis of PSS, and gather information from multicenter studies to ultimately provide appropriate and effective care for children with PSS.